Concepedia

Lorna Castaneda

LC

Statistics

Publications

9

Citations

367

H-Index

9

Active since

1969

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Bioanalytical Systems (United States)

Bristol-Myers Squibb (Sweden)

Lorna Castaneda is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, clinical pharmacology, and medicine.

Publications per year

1969–2012

9

Publications

9

Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Saxagliptin

David W. Boulton, Li Li, Ernst U. Frevert et al. · Clinical Pharmacokinetics · 2011 · 108 citations

, , +12

Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of the Oral γ-Secretase Inhibitor BMS-708163 (Avagacestat): Tolerability Profile, Pharmacokinetic Parameters, and Pharmacodynamic Markers

Gary Tong, Junsheng Wang, Oleksandr Sverdlov et al. · Clinical Therapeutics · 2012 · 65 citations

, , +6

Pharmacodynamics of Selective Inhibition of γ-Secretase by Avagacestat

Charles F. Albright, Randy Dockens, Jere E. Meredith et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 63 citations

, , +17

A Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Avagacestat (BMS-708163) in Healthy Young and Elderly Subjects

Randy Dockens, Junsheng Wang, Lorna Castaneda et al. · Clinical Pharmacokinetics · 2012 · 47 citations

, , +8

Effects of Single Doses of Avagacestat (BMS-708163) on Cerebrospinal Fluid Aβ Levels in Healthy Young Men

Gary Tong, Lorna Castaneda, Junsheng Wang et al. · Clinical Drug Investigation · 2012 · 35 citations

, , +8

1–5 of 9